SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Return on equity 2024–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-102.5%FY2025 · since FY2024: 48.1% → -102.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -102.5% | -150.6 pp |
| FY2024 | 48.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →